Radiopharmaceutical doses (X4).

Ended Awarded

Contract number
HT009022FG0110021
Awardee
Awarding agency
Obligated
$13,984

Award facts

Contract value 100% obligated
$13,984.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
Q527 Medical- Nuclear Medicine
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Sterling, VA, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

Sofie Co., a subsidiary of Sofie Biosciences, Inc., has been awarded a $13,984 firm fixed price call against the Defense Health Agency's Basic Purchasing Agreement to provide radiopharmaceutical doses for diagnostic imaging procedures. Under this contract, Sofie will deliver the requested pharmaceutical products to support imaging services at facilities located in Sterling, Virginia, with all work to be completed by September 30, 2022. No set-aside provisions were applied to this award to fulfill the Defense Health Agency's requirements.

Quick answers

Who was awarded contract HT009022FG0110021?

HT009022FG0110021 was awarded to Sofie CO. by Defense Health Agency (Department of Defense) on January 25, 2022.

How much is contract HT009022FG0110021 worth?

The government has obligated $13,984 on HT009022FG0110021.

Is contract HT009022FG0110021 an order under another contract?

Yes. HT009022FG0110021 is a BPA call under HT001421A0014, a blanket purchase agreement.

Was contract HT009022FG0110021 competed?

The extent of competition for HT009022FG0110021 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login